Evox Therapeutics

Developer of exosome-based therapeutics for severe neurological and rare diseases

placeOxford, England, United Kingdom calendar_todayFounded 2016 groups73 employees language evoxtherapeutics.com

Registered entities

Social engagement

Social engagement: 13.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

28 investors on record; lead investors include Gates, Redmile Group, Oxford Science Enterprises.

Investor typeCountShare
Venture capital621%
Private equity311%
Accelerator & incubator14%
Bank & private debt14%
Other / undisclosed1761%

Recent activity

20 Jun 2026
Event
BIO International Convention
26 May 2026
Event
UK Biotech Day 2026
4 May 2026
Event
Bio€quity Europe
Coming soon